Trial Condition(s):

Bacterial Infection

Ciprofloxacin (sequential IV/PO, Intravenous/Peroral) in pediatric cystic fibrosis patients with acute pulmonary exacerbation

Bayer Identifier:

Trial_1359

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available

Study Completed

Trial Purpose

Please see attached Study Results Summary below

Inclusion Criteria

No Inclusion Criteria Available

Exclusion Criteria

No Exclusion Criteria Available

Trial Summary

Enrollment Goal

Trial Dates

August1992

August1994

Phase

N/A

Could I receive a placebo?

Products

Cipro IV (Ciprofloxacin, BAYQ3939)

Accepts Healthy Volunteers

N/A

Where to Participate

Locations

Locations

For details, please refer to trial results

Additional Information

Not Available

Bacterial Infection

Bayer Identifier:

ClinicalTrials.gov Identifier:

EudraCT Number:

EU CT Number:

Trial Purpose

Key Participation Requirements

sex

age

5 Years

17 Years

Inclusion Criteria

Exclusion Criteria

Inclusion Criteria

Exclusion Criteria

Trial Summary

Enrollment Goal

Trial Dates

Phase

Could I receive a placebo?

Products

Accepts Healthy Volunteers

Where to Participate

For details, please refer to trial results

Additional Information